WALL, N.J., Feb. 28, 2012 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (OTCBB:BKYI), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that Jim Sullivan, Director of Sales, is scheduled to present at the 2012 Winter Biometric Summit in Miami, Florida. Mr. Sullivan will join Nancy Gibson, Manager of Biometric Authentication Solutions, LexisNexis Risk Solutions and Eric Schulties, Vice President and Chief Information Officer, Institute for Transfusion Medicine, to present "Leveraging Fingerprint Identification to Effectively Eliminate Duplicate Records and Streamline Business Processes" at 11:15am on Tuesday, February 28th, 2012.
The Winter Biometric Summit presents a forum to present and learn about the latest advances in practical deployment strategies, market trends and best practices in business and government as they relate to biometric technology solutions.
"The acceptance of fingerprint biometric technology as a practical safe and convenient identification solution is growing daily. It's apparent that the days for traditional passwords are just like the characters they utilize; they're numbered," said Jim Sullivan, Director of Sales, BIO-key International. "The stakes have simply become too high; technology which makes us all better, has also put us at risk. Businesses and the government are pressed to find better solutions and the consumer is growing tired of maintaining passwords for every application. Biometrics can play a significant role in solving many of the issues and we're all glad to witness emerging levels of acceptance," added Sullivan.
Nick Ivon, Clark and Daughtrey Medical Group P.A. will present on the "Implementation of Biometrics and Single Sign-on for Access to Electronic Health Records." BIO-key already provides fingerprint biometric technology to hundreds of hospitals throughout the United States.
Nick Menga, Unit Chief, CJIS, Federal Bureau of Investigations (FBI), will present the "FBI Next Generation Identification Program: Understanding and Preparing for Multimodal Functionality." BIO-key is extremely proud to be one of the technology solution providers for the FBI's Next Gen ID program.
About BIO-key
BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key's award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world's largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key's technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)
BIO-key Safe Harbor Statement
Certain statements contained in this press release may be construed as "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2010 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.